antibody-drug conjugate

Daiichi Sankyo to invest $135M in ADC manufacturing expansion
Daiichi Sankyo to invest $135M in ADC manufacturing expansion
BioPharma Dive
Daiichi Sankyo
drug manufacturing
antibody-drug conjugate
Flag link:
AstraZeneca backs $80M round for ADC's antibody warhead tech
AstraZeneca backs $80M round for ADC's antibody warhead tech
Fierce Biotech
AstraZeneca
ADC Therapeutics
antibody-drug conjugate
Flag link:
Seattle Genetics: Good Tech, But On The Wrong Path
Seattle Genetics: Good Tech, But On The Wrong Path
Seeking Alpha
Seattle Genetics
antibody-drug conjugate
Flag link:
Keep an Eye on These 3 Revolutionary Cancer Treatments in 2014
Keep an Eye on These 3 Revolutionary Cancer Treatments in 2014
Motley Fool
cancer
Roche
Infinity Pharmaceuticals
Inovio
Immunogen
Gilead Sciences
immunotherapy
antibody-drug conjugate
Flag link:
Weighing Out The Seattle Genetics Barbell
Weighing Out The Seattle Genetics Barbell
Seeking Alpha
Seattle Genetics
antibody-drug conjugate
Adcetris
Flag link:
AstraZeneca to Pay Up to $440 Million for Spirogen
AstraZeneca to Pay Up to $440 Million for Spirogen
Bloomberg
Spirogen
AstraZeneca
M&A
antibody-drug conjugate
ADC Therapeutics
MedImmune
Flag link:
Immunomedics Advances Solid Tumor Antibody-Drug Conjugate Programs to Phase II Clinical Trials
Immunomedics Advances Solid Tumor Antibody-Drug Conjugate Programs to Phase II Clinical Trials
Yahoo
Immunomedics
solid tumors
antibody-drug conjugate
Flag link:
Seattle Genetics, Astellas affiliate announce co-development of added ADC
Seattle Genetics, Astellas affiliate announce co-development of added ADC
The Fly on the Wall
Seattle Genetics
antibody-drug conjugate
Astellas
ASG-15ME
Agensys
bladder cancer
lung cancer
Flag link:
Seattle Genetics, Bayer to Develop Less Symptomatic Cancer Drug
Seattle Genetics, Bayer to Develop Less Symptomatic Cancer Drug
FOX Business
Seattle Genetics
Bayer
antibody-drug conjugate
Flag link:
Pfizer turns to upstart CytomX for $635M deal on armed antibody tech
Pfizer turns to upstart CytomX for $635M deal on armed antibody tech
Fierce Pharma
CytomX
Pfizer
antibody-drug conjugate
Flag link:
How High Can Seattle Genetics Fly?
How High Can Seattle Genetics Fly?
Motley Fool
Seattle Genetics
antibody-drug conjugate
Flag link:
ASCO spotlight: Antibody-drug conjugates arrive
ASCO spotlight: Antibody-drug conjugates arrive
Fierce Biotech
ASCO
antibody-drug conjugate
Roche
Genentech
Immunogen
T-DM1
Adcetris
Seattle Genetics
Flag link:
Seattle Genetics: Innovative Biotech, Speculative Stock
Seattle Genetics: Innovative Biotech, Speculative Stock
Seeking Alpha
Seattle Genetics
antibody-drug conjugate
Flag link:
Seattle Genetics shares rise in heavy trading
Seattle Genetics shares rise in heavy trading
Bizjournals.com
Seattle Genetics
antibody-drug conjugate
Flag link:
Seattle Genetics Announces Antibody-Drug Conjugate Collaboration with Abbott
Seattle Genetics Announces Antibody-Drug Conjugate Collaboration with Abbott
Yahoo
Abbott Laboratories
antibody-drug conjugate
Seattle Genetics
Flag link:
Millennium expands cancer pact with red-hot Seattle Genetics
Millennium expands cancer pact with red-hot Seattle Genetics
Fierce Biotech
Millennium
Seattle Genetics
antibody-drug conjugate
Flag link:

Pages